ClinicalTrials.gov
ClinicalTrials.gov Menu

Single-Blind, Controlled Safety and Immunogenicity Study of Recombinant MVA Virus to Treat HIV Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00390078
Recruitment Status : Completed
First Posted : October 19, 2006
Last Update Posted : July 10, 2009
Sponsor:
Collaborator:
National Institutes of Health (NIH)
Information provided by:
Bavarian Nordic

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2007
  Actual Study Completion Date : January 2009